Skip to content

NIS-2 Directive and Laboratory Medicine

The NIS-2 Directive is an important EU regulation that aims to ensure a high level of cybersecurity throughout the European Union¹. It is the successor to the first NIS Directive and introduces several significant changes that must be transposed into national law by October 2024¹.

For medical laboratories, this means they must prepare for stricter security requirements. Here are some key aspects that medical laboratories should consider:

1. Risk Management: Medical laboratories must implement comprehensive risk management that identifies, assesses, and takes appropriate protective measures against cyber threats?.
  
2. Reporting Procedures: A procedure must be established to properly report security incidents to the competent authorities?.
  
3. Business Continuity: Laboratories must develop business continuity plans to maintain operations in the event of a cyber incident?.
  
4. Management Responsibility: Management is responsible for compliance with the directive and must ensure that all requirements are met?.
  
5. Cooperation with Authorities: Closer cooperation with government agencies such as the Federal Office for Information Security (BSI) is expected to strengthen cybersecurity¹.

It is important for medical laboratories to take these requirements seriously and take appropriate measures to ensure the security of their data and systems. The NIS-2 Directive aims to increase resilience against cyberattacks and create a secure digital space in the EU.


(1) BSI – NIS Directives. https://www.bsi.bund.de/DE/Das-BSI/Auftrag/Gesetze-und-Verordnungen/NIS-Richtlinien/nis-richtlinie_node.html.


(2) NIS-2 Directive in Medical Technology – BVMed. https://bing.com/search?q=Anforderungen+f%c3%bcr+Medizinlabore+NIS-2+Richtlinie.


(3) NIS-2: Everything you need to know about the new directive – PwC. https://www.pwc.de/de/cyber-security/europaeische-nis-2-richtlinie-implikationen-fuer-unternehmen-und-institutionen.html.


(4) NIS-2 Directive published in the EU Official Journal. https://www.bsi.bund.de/DE/Themen/KRITIS-und-regulierte-Unternehmen/Kritische-Infrastrukturen/KRITIS-aktuell/KRITIS-Meldungen/221227-veroeffentlichung-nis-2.html.


(5) NIS-2: Everything you need to know about the new directive – PwC. https://bing.com/search?q=NIS-2+Richtlinie.
(6) NIS2 Directive: Overview | TÜV NORD. https://www.tuev-nord.de/de/unternehmen/bildung/wissen-kompakt/nis2-richtlinie/.


(7) New Developments through the NIS-2 Directive | EY Law – Germany. https://ey-law.de/de_de/rechtsberatung/neuerungen-durch-die-nis-2-richtlinie.
(8) NIS-2 Directive in Medical Technology – BVMed. https://www.bvmed.de/themen/infektionsschutz/2024-09-09-ba-nis2.


(9) NIS-2: Requirements for the Healthcare Sector – PwC. https://www.pwc.de/de/cyber-security/europaeische-nis-2-richtlinie-implikationen-fuer-unternehmen-und-institutionen/nis-2-anforderungen-an-den-healthcare-sektor.html.


(10) NIS-2 Directive: What is now important for companies | G DATA. https://www.gdata.de/business/nis-2-richtlinie.


(11) undefined. https://www.bsi.bund.de/dok/kritis-aktuell.

author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
Keywords:
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu